Acquired Antithrombin Deficiency clinical trials

Explore recruiting acquired antithrombin deficiency clinical trials.

Recruiting acquired antithrombin deficiency studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Acquired Antithrombin Deficiency trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Phase 3, double-blind, placebo-controlled, multicentre study on the efficacy and safety of human plasma derived antithrombin (Atenativ) in heparin-resistant patients scheduled to undergo cardiac surgery necessitating cardiopulmonary bypass

Lithuania, Slovenia, Austria, Romania, Czechia, France +2 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Acquired Antithrombin Deficiency trials by city

Acquired Antithrombin Deficiency in Toronto Acquired Antithrombin Deficiency in Vancouver Acquired Antithrombin Deficiency in Montreal Acquired Antithrombin Deficiency in Calgary Acquired Antithrombin Deficiency in Edmonton Acquired Antithrombin Deficiency in Ottawa Acquired Antithrombin Deficiency in Winnipeg Acquired Antithrombin Deficiency in Quebec City Acquired Antithrombin Deficiency in Hamilton Acquired Antithrombin Deficiency in Kitchener Acquired Antithrombin Deficiency in London Acquired Antithrombin Deficiency in Halifax Acquired Antithrombin Deficiency in New York Acquired Antithrombin Deficiency in Los Angeles Acquired Antithrombin Deficiency in Chicago Acquired Antithrombin Deficiency in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease